1st Quarter - Report

FIDELIS GOVERNMENT RELATIONS for EXELA PHARMA SCIENCES

Period 1st Quarter 2021 Filed Apr 12, 2021 Signed by Terry Allen

Official filing
Firm
FIDELIS GOVERNMENT RELATIONS
Client
EXELA PHARMA SCIENCES
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Covid Vaccine support and regulatory issues

LobbyistCovered position, as disclosed
TERRY ALLEN Chief of Staff, Rep. Steve Largent
WAYNE KING Deputy Chief of Staff, Rep. Mark Meadows

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); President of the U.S.; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.